First randomized clinical trial found no harms from dementia screening in primary care

(Regenstrief Institute) In the first randomized controlled trial to evaluate pros and cons of population screening for dementia, Regenstrief Institute and Indiana University School of Medicine researchers found no harm, as measured by patient reported depressive and anxiety symptoms, from screening for Alzheimer's disease and related dementia in diverse rural, suburban and urban primary care clinics.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news